Dr. Gary Gan is a Clinical and Academic Heart Failure Cardiologist based in Sydney. Renowned for his dynamic leadership and commitment to excellence in patient care, Dr. Gan holds senior appointments across several leading institutions, including Westmead, Blacktown, and Ryde Hospitals. He currently serves as the Director of Heart Failure Services at both Westmead and Blacktown Hospitals, where he oversees the multidisciplinary heart failure clinics and advanced heart failure unit. In addition, he is the Clinical Lead for Cardiac Imaging at Ryde Hospital, playing a pivotal role in enhancing diagnostic capabilities and fostering innovation in cardiovascular imaging. On the international stage, Dr. Gan is the Co-Chair of the Emerging Leaders Heart Failure Committee for the Asia Pacific Society of Cardiology, where he champions regional collaboration and the development of future leaders in the field of heart failure. Dr. Gan is a Senior Conjoint Lecturer with the University of Sydney. His academic interests lie at the complex intersection of cardiovascular disease and chronic kidney disease.

Dr Jonathan Ciofani is a cardiology registrar and researcher at Royal North Shore Hospital with clinical interests in interventional cardiology, structural heart disease and genomics. He holds a Master of Public Health from Imperial College London, and a Doctor of Medicine and Bachelor of Medical Science from The University of Sydney. Jonathan currently Chairs the CSANZ Fellows in Training Committee, is member of the CSANZ Education Committee, and is Section Editor for Genomics and Precision Medicine at Heart, Lung and Circulation.

Director, Nuclear Cardiology, National Heart Centre, Singapore. Clinical Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore and Duke NUS Medical School.

Associate Professor Rebecca Kozor is a consultant cardiologist and cardiac imaging specialist at Royal North Shore Hospital and the University of Sydney.

Keyvan Karimi is an academic interventional cardiologist and clinician-scientist based in Sydney, and a Senior Lecturer at the University of Sydney. His research spans vascular biology, translational science and clinical trials, with a focus on coronary artery disease. His work uses invasive and non-invasive imaging to define atherosclerotic burden, guide prevention and optimise interventional treatment. His research also encompasses novel pharmacotherapies and devices, with a broader focus on translating advances in cardiovascular science into better prevention and treatment of coronary disease.

Dr Jie Yu is a cardiologist and researcher with clinical and academic experience across China and Australia. She completed her MD and PhD at Peking University and previously worked as a Consultant Cardiologist and Associate Professor at Peking University Third Hospital. After moving to Australia, Jie undertook cardiovascular research at The George Institute for Global Health and further cardiology training at Royal North Shore Hospital and John Hunter Hospital. She now practises across public and private cardiology settings in New South Wales and is a Conjoint Senior Lecturer at the University of Newcastle. Her clinical interests include coronary artery disease, heart failure, cardio-oncology, echocardiography, hypertension and preventive cardiology. Her research spans basic science, clinical trials and health-services research. She previously served as Co-Deputy Director of the Heart and Stroke Program at the Hunter Medical Research Institute and continues to supervise medical student research projects.

Dr Baumann is an Imaging and General Cardiologist based in Mparntwe/Alice Springs, with professional interests in rural cardiac care, Indigenous health, CTCA and the management of rheumatic heart disease.

Gemma is a Professor in Medicine at the University of Sydney and an Interventional Cardiologist at Royal North Shore Hospital in Sydney. She is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma is committed to improving the care for heart attack patients, unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals including the Lancet, Circulation, JACC and European Heart Journal, with > 250 publications. Gemma is a principal investigator on grants >$42 Mill. Her discoveries and innovative strategies have resulted in a US patent, and 5 provisional patents spanning diagnostic and therapeutic fields. Gemma is founder and CSO for Australian start-ups Prokardia and Kardiomics, and the not-for-profit CAD Frontiers Pty Ltd. She was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia- 2018), NSW Ministerial Award for Cardiovascular Research Excellence (2019) and was the second female to be awarded the prestigious Cardiac Society of Australia and New Zealand RT Hall Prize for outstanding and sustained research achievement (2023). Gemma serves as a member of the Editorial Board of leading international journals including Circulation and Cardiovascular Research and an Associate Editor for Heart, Lung and Circulation. She is a passionate advocate for cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, and to build new pathways for research to best serve the unmet health needs of Australians. She chairs the MRFF Mission (CV) Expert Advisory Panel. She is a graduate of the Australian Institute of Company Directors and serves/has served as a non-executive Director on multiple community Boards, including the Heart Foundation. In 2023, Gemma was appointed a Member of the Order of Australia (AM), in the Australia Day Honours.

Dr Lund is a cardiologist at Counties Manukau District and the clinical lead for the Northern Region Cardiac Network. Her professional mission is “To provide world class cardiology care to a population who too often have no choice where they receive treatment”. Dr Lund specialises in community heart failure care. She was the first woman to Chair the New Zealand Committee of CSANZ, and is the current President of CSANZ.